Kawin Overview

  • Founded
  • 2008
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 4

Kawin General Information


Developer of innovative biopharmaceutical products focusing on liver disease treatment. The company is committed to developing high-quality healthcare products especially for the treatment of various liver-related diseases including liver cancer and hepatitis C.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Primary Office
  • 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kawin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jan-2017 Completed Generating Revenue
2. Later Stage VC 01-Mar-2015 Completed Generating Revenue
1. Early Stage VC 29-Jul-2011 Completed Generating Revenue
To view Kawin’s complete valuation and funding history, request access »

Kawin Executive Team (2)

Name Title Board Seat Contact Info
Desheng Zhou MD Chairman & President
Yunde Hou Founder
To view Kawin’s complete executive team members history, request access »

Kawin Board Members (6)

Name Representing Role Since
Desheng Zhou MD Kawin Chairman & President 000 0000
Hui Li Self Board Member 000 0000
Liping Zhang Self Board Member 000 0000
Ningning Ma Self Board Member 000 0000
Qingmin Wu Self Co-Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Kawin Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gaolin Capital Venture Capital Minority 000 0000 000000 0
YuanBio Venture Capital Venture Capital Minority 000 0000 000000 0
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
Legend Capital Venture Capital Minority 000 0000 000000 0
To view Kawin’s complete investors history, request access »

Kawin Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 11-Jan-2019 00000 00000 00 000.00 Biotechnology
Ginkgo 01-Jan-2015 Corporate Drug Discovery
To view Kawin’s complete investments history, request access »